Ejaculatory Disorders Caused by Alpha-1 Blockers for Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Comparison of Naftopidil and Tamsulosin in a Randomized Multicenter Study

Naoya Masumori; Taiji Tsukamoto; Akihiko Iwasawa; Ryoji Furuya; Tomoko Sonoda; Mitsuru Mori

doi:10.1159/000224868

Ejaculatory Disorders Caused by Alpha-1 Blockers for Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Comparison of Naftopidil and Tamsulosin in a Randomized Multicenter Study

Urologia Internationalis ◽

10.1159/000224868 ◽

2009 ◽

Vol 83 (1) ◽

pp. 49-54 ◽

Cited By ~ 17

Author(s):

Naoya Masumori ◽

Taiji Tsukamoto ◽

Akihiko Iwasawa ◽

Ryoji Furuya ◽

Tomoko Sonoda ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

Progression of Lower Urinary Tract Symptoms After Discontinuation of 1 Medication From 2-Year Combined Alpha-blocker and 5-Alpha–reductase Inhibitor Therapy for Benign Prostatic Hyperplasia in Men – A Randomized Multicenter Study

Urology ◽

10.1016/j.urology.2013.09.036 ◽

2014 ◽

Vol 83 (2) ◽

pp. 416-421 ◽

Cited By ~ 11

Author(s):

Victor Chia-Hsiang Lin ◽

Chun-Hou Liao ◽

Hann-Chorng Kuo

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Reductase Inhibitor ◽

Prostatic Hyperplasia ◽

Alpha Blocker ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily

Urologia Internationalis ◽

10.1159/000315994 ◽

2010 ◽

Vol 85 (1) ◽

pp. 80-87 ◽

Cited By ~ 8

Author(s):

Shinji Tsuritani ◽

Tetsuo Nozaki ◽

Akiou Okumura ◽

Hitomi Kimura ◽

Taizo Kazama

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

A randomized, open-label, multicenter study evaluating efficacy of switch from dutasteride to tadalafil in benign prostatic hyperplasia patient with lower urinary tract symptoms (D-to-T trial)

European Urology Supplements ◽

10.1016/s1569-9056(17)30594-8 ◽

2017 ◽

Vol 16 (3) ◽

pp. e928

Author(s):

T. Matsumoto ◽

S. Hatakeyama ◽

K. Yoshikawa ◽

K. Fukui ◽

T. Yanagisawa ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Benign Prostatic Hyperplasia Patient ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized multicenter study

International Journal of Urology ◽

10.1111/iju.12055 ◽

2012 ◽

Vol 20 (9) ◽

pp. 903-910 ◽

Cited By ~ 9

Author(s):

Toshiro Shirakawa ◽

Takahiro Haraguchi ◽

Katsumi Shigemura ◽

Shinichi Morishita ◽

Kohji Minayoshi ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Japanese Patients ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open‐label, multicenter study

International Journal of Urology ◽

10.1111/iju.13908 ◽

2019 ◽

Vol 26 (4) ◽

pp. 522-523 ◽

Cited By ~ 1

Author(s):

Teppei Matsumoto ◽

Shingo Hatakeyama ◽

Takuma Narita ◽

Takahiro Yoneyama ◽

Yasuhiro Hashimoto ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

1242: Lower Urinary Tract Symptoms Severity and International Prostate Symptom Score Bother Question Correlate with Measures of Erectile and Ejaculatory Dysfunction in Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/s0022-5347(18)35387-4 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 337-337

Author(s):

Raymond C. Rosen ◽

Kevin T. McVary ◽

James Nuckolls ◽

Richard Payne ◽

Allen D. Seftel ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Symptom Score ◽

Lower Urinary Tract Symptoms ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Ejaculatory Dysfunction ◽

Lower Urinary

Download Full-text

Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

Minerva Urologica e Nefrologica ◽

10.23736/s0393-2249.19.03408-8 ◽

2020 ◽

Vol 72 (1) ◽

Cited By ~ 5

Author(s):

Yi Sun ◽

Bo Peng ◽

Guo-Lin Lei ◽

Qiang Wei ◽

Lu Yang

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Lower Urinary

Download Full-text

Faculty Opinions recommendation of Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2111965.1706064 ◽

2010 ◽

Author(s):

Peter Gilling ◽

Liam Wilson

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Lower Urinary

Download Full-text

Faculty Opinions recommendation of Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718145684.793486561 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Symptom Score ◽

Lower Urinary Tract Symptoms ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Combined Therapy ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Lower Urinary

Download Full-text